pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
MRT-6160
Axial Spondyloarthritis
$NVS
NOVARTIS AG
0
catalysts
Phase 1
MRT-8102
Inflammation
$GLUE
Monte Rosa Therapeutics, Inc.
0
catalysts
Phase 1
MRX-2843
Non-Small Cell Lung Cancer
Meryx Inc
0
catalysts
Phase 1
← prev
page 109 of 231
next →
131
Pain
89
Neurology
1
MRX-8
Acinetobacter Infections
MicuRx Pharmaceuticals Inc
0
catalysts
Preclinical
MSC-2
Optic Neuritis
SanBio Co Ltd
0
catalysts
Preclinical
MSCKD
Acute Renal Failure (ARF) (Acute Kidney Injury)
Orgenesis Inc
0
catalysts
Phase 1
MT-101
Parkinson's Disease
MThera Pharma Co Ltd
0
catalysts
Phase 2
MT-125
Glioblastoma Multiforme (GBM)
Myosin Therapeutics Inc
0
catalysts
Phase 2
MT-2990
Endometriosis
Tanabe Pharma Corp
0
catalysts
Phase 2
MTG-201
Prostate Cancer
Momotaro-Gene Inc
0
catalysts
Phase 1
MTI-201
Metastatic Uveal Melanoma
Modulation Therapeutics Inc
0
catalysts
Phase 2
MTL-CEBPA
Hepatocellular Carcinoma
Mina Therapeutics Ltd
0
catalysts
Phase 2
MTX-001
Venous Leg Ulcers (Crural Ulcer)
Merakris Therapeutics Inc
0
catalysts
Phase 2
MTX-463
Idiopathic Pulmonary Fibrosis
Eli Lilly and Co
0
catalysts
Phase 2
MTX-652
Acute Renal Failure (ARF) (Acute Kidney Injury)
Mission Therapeutics Ltd
0
catalysts
MUCINEX DM MAXIMUM STRENGTH
MUCINEX DM MAXIMUM STRENGTH (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE)
RB HLTH
0
catalysts
MUCUS DM
MUCUS DM (DEXTROMETHORPHAN HBR, GUAIFENESIN)
PERRIGO R AND D
0
catalysts
MUCUS RELIEF DM MAXIMUM STRENGTH
MUCUS RELIEF DM MAXIMUM STRENGTH (GUAIFENESIN AND DEXTROMETHORPHAN HBR)
AUROBINDO PHARMA
0
catalysts
Preclinical
MUL-001
Neurofibromatoses Type II
Mulberry Biotherapeutics Inc
0
catalysts
MULTIHANCE
MULTIHANCE (GADOBENATE DIMEGLUMINE)
BRACCO
0
catalysts
MULTIPLE ELECTROLYTES PH 5.5
MULTIPLE ELECTROLYTES PH 5.5 (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE)
FRESENIUS KABI USA
0
catalysts
Phase 2
MVAmBN-396
Eastern Equine Encephalitis
Bavarian Nordic AS
0
catalysts
Phase 2
MVCCOV-1901
Coronavirus Disease 2019 (COVID-19)
Medigen Vaccine Biologics Corp
0
catalysts
Preclinical
MVP-0601
Malignant Pleural Mesothelioma
OncoVITA SAS
0
catalysts
Preclinical
MVREX-101
Wounds
Immvira Co Ltd
0
catalysts
Preclinical
MVREX-104
Androgenic Alopecia
Immvira Co Ltd
0
catalysts
Preclinical
MVREX-107
Pulmonary Fibrosis
Immvira Co Ltd
0
catalysts
Phase 2
MVRT-3011
Recurrent Head And Neck Squamous Cell Carcinoma
Immvira Co Ltd
0
catalysts
Phase 2
MVX-220
Angelman Syndrome
Mavrix Bio LLC
0
catalysts
Phase 2
MWTx-01
Polycythemia Vera
$IRON
Disc Medicine, Inc.
0
catalysts
